McCann Healthcare Loses Avodart to Cramer-Krasselt

McCann Healthcare has lost the Avodart account, a GlaxoSmithKline product that helps relieve problems associated with an enlarged prostate. The account has landed with Cramer-Krasselt, we’ve confirmed with a source close to the matter.

We’re told that this does not affect other GSK accounts held by McCann.

More: “Curt Detweiler to EVP/ECD at McCann North America”

Launch a social media campaign that will build your brand and deliver results in our online Social Media Marketing Boot Camp starting June 7. Speakers include Abigail Cusick (Bravo Digital), Gregory Galant (Sawhorse Media), Alex Leo (Thomson Reuters Digital), Jim Tobin (Ignite Social Media), and many more. Read the reviews.